Cargando…

Bridging: Accelerating Regulatory Acceptance of Reduced-Risk Tobacco and Nicotine Products

INTRODUCTION: The number and variety of alternative tobacco and nicotine products that can potentially provide reduced-risk choices for cigarette smokers who switch completely to such products instead of continued smoking have grown substantially in the past decade. Innovation and choice are likely...

Descripción completa

Detalles Bibliográficos
Autores principales: Gaca, Marianna, Williamson, Justine, Digard, Helena, Adams, Louise, Hawkridge, Lauren, Proctor, Christopher
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9356683/
https://www.ncbi.nlm.nih.gov/pubmed/35171296
http://dx.doi.org/10.1093/ntr/ntac041
_version_ 1784763572504494080
author Gaca, Marianna
Williamson, Justine
Digard, Helena
Adams, Louise
Hawkridge, Lauren
Proctor, Christopher
author_facet Gaca, Marianna
Williamson, Justine
Digard, Helena
Adams, Louise
Hawkridge, Lauren
Proctor, Christopher
author_sort Gaca, Marianna
collection PubMed
description INTRODUCTION: The number and variety of alternative tobacco and nicotine products that can potentially provide reduced-risk choices for cigarette smokers who switch completely to such products instead of continued smoking have grown substantially in the past decade. Innovation and choice are likely to improve the prospects of smokers making the switch, but this provides challenges to regulators and manufacturers to ensure that changes to regulations and products promote and do not hinder contributions to tobacco harm reduction. AIMS AND METHODS: This paper looks at where bridging data sets for tobacco heating products, closed system vaping products, and oral nicotine products might enable innovation while protecting the interests of consumers. RESULTS: We review product data from chemical studies and a toxicological study showing how bridging can be applied and consider what product development changes might allow bridging from existing datasets or trigger the need for new ones. CONCLUSIONS: Bridging across specific product ranges can increase the speed of innovation, foster competition, and limit the burden of assessment for regulators while maintaining product safety and quality. IMPLICATIONS: Bridging partial data sets is an established practice within other industries, that aims to improve efficiency with regulatory approvals, accepts natural product variation, and supports product innovation. We review product data from chemical studies and a toxicological study showing how bridging can be applied and consider what product development changes might allow bridging from existing datasets or trigger the need for new ones. This in turn can increase the speed of innovation, foster competition, and limit the burden of assessment for regulators while maintaining product safety and quality.
format Online
Article
Text
id pubmed-9356683
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-93566832022-08-09 Bridging: Accelerating Regulatory Acceptance of Reduced-Risk Tobacco and Nicotine Products Gaca, Marianna Williamson, Justine Digard, Helena Adams, Louise Hawkridge, Lauren Proctor, Christopher Nicotine Tob Res Original Investigations INTRODUCTION: The number and variety of alternative tobacco and nicotine products that can potentially provide reduced-risk choices for cigarette smokers who switch completely to such products instead of continued smoking have grown substantially in the past decade. Innovation and choice are likely to improve the prospects of smokers making the switch, but this provides challenges to regulators and manufacturers to ensure that changes to regulations and products promote and do not hinder contributions to tobacco harm reduction. AIMS AND METHODS: This paper looks at where bridging data sets for tobacco heating products, closed system vaping products, and oral nicotine products might enable innovation while protecting the interests of consumers. RESULTS: We review product data from chemical studies and a toxicological study showing how bridging can be applied and consider what product development changes might allow bridging from existing datasets or trigger the need for new ones. CONCLUSIONS: Bridging across specific product ranges can increase the speed of innovation, foster competition, and limit the burden of assessment for regulators while maintaining product safety and quality. IMPLICATIONS: Bridging partial data sets is an established practice within other industries, that aims to improve efficiency with regulatory approvals, accepts natural product variation, and supports product innovation. We review product data from chemical studies and a toxicological study showing how bridging can be applied and consider what product development changes might allow bridging from existing datasets or trigger the need for new ones. This in turn can increase the speed of innovation, foster competition, and limit the burden of assessment for regulators while maintaining product safety and quality. Oxford University Press 2022-02-16 /pmc/articles/PMC9356683/ /pubmed/35171296 http://dx.doi.org/10.1093/ntr/ntac041 Text en © The Author(s) 2022. Published by Oxford University Press on behalf of the Society for Research on Nicotine and Tobacco. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Investigations
Gaca, Marianna
Williamson, Justine
Digard, Helena
Adams, Louise
Hawkridge, Lauren
Proctor, Christopher
Bridging: Accelerating Regulatory Acceptance of Reduced-Risk Tobacco and Nicotine Products
title Bridging: Accelerating Regulatory Acceptance of Reduced-Risk Tobacco and Nicotine Products
title_full Bridging: Accelerating Regulatory Acceptance of Reduced-Risk Tobacco and Nicotine Products
title_fullStr Bridging: Accelerating Regulatory Acceptance of Reduced-Risk Tobacco and Nicotine Products
title_full_unstemmed Bridging: Accelerating Regulatory Acceptance of Reduced-Risk Tobacco and Nicotine Products
title_short Bridging: Accelerating Regulatory Acceptance of Reduced-Risk Tobacco and Nicotine Products
title_sort bridging: accelerating regulatory acceptance of reduced-risk tobacco and nicotine products
topic Original Investigations
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9356683/
https://www.ncbi.nlm.nih.gov/pubmed/35171296
http://dx.doi.org/10.1093/ntr/ntac041
work_keys_str_mv AT gacamarianna bridgingacceleratingregulatoryacceptanceofreducedrisktobaccoandnicotineproducts
AT williamsonjustine bridgingacceleratingregulatoryacceptanceofreducedrisktobaccoandnicotineproducts
AT digardhelena bridgingacceleratingregulatoryacceptanceofreducedrisktobaccoandnicotineproducts
AT adamslouise bridgingacceleratingregulatoryacceptanceofreducedrisktobaccoandnicotineproducts
AT hawkridgelauren bridgingacceleratingregulatoryacceptanceofreducedrisktobaccoandnicotineproducts
AT proctorchristopher bridgingacceleratingregulatoryacceptanceofreducedrisktobaccoandnicotineproducts